Luna Overnight Automated Insulin Delivery System
Glycemic control in diabetes (for Multiple Daily Injection users)
Key Facts
About Luna Diabetes
Luna Diabetes is a private, pre-revenue digital health startup founded in 2019 by industry veterans with deep personal and professional experience in diabetes care. The company is developing 'Luna,' an investigational automated insulin delivery device that attaches to standard insulin pens to provide overnight glycemic control for users on multiple daily injection (MDI) therapy, a significant and underserved market segment. By focusing exclusively on nighttime automation, Luna seeks to offer a simpler, more accessible alternative to traditional insulin pumps, potentially improving outcomes for millions of patients. The company is currently in the development and testing phase, gathering clinical validation and preparing for regulatory submission and commercial launch.
View full company profile